We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RYET:NASDAQRuanyun Edai Technology Inc. Analysis

Data as of 2026-09-05 - not real-time

$0.85

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Ruanyun Edai Technology Inc. is bearish at $0.8484, with short-term averages lagging the long-term ones. It has lost 18.1% over the past 30 days. Momentum indicators put RSI at 34.5 (approaching oversold) with MACD reading bearish. Recent trading has carved out support near $0.7870 and resistance around $1.10.
Revenue is growing at 176.2% on a -105.0% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 52.3%, a beta of 1.34 and a maximum drawdown of 51.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to sell, carrying 4/10 conviction.

Top Market Events

NANCHANG, China, Aug. 05, 2026 GLOBE NEWSWIRE -- Ruanyun Edai Technology Inc. NASDAQ: RYET 'Ruanyun,' 'RYET' or the...KUALA LUMPUR, Malaysia, Aug. 03, 2026 GLOBE NEWSWIRE -- Ruanyun Edai Technology Inc. NASDAQ: RYET 'Ruanyun,' 'RYET' or...New York, NY, Feb. 19, 2026 GLOBE NEWSWIRE -- Ruanyun Edai Technology Inc. Nasdaq: RYET, the “Company” today...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.05
  • MACD momentum is negative

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.05
  • 30-day volatility of 52.3%

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Negative profit margin of -105.0%
  • Negative return on equity of -331.4%
  • Revenue growth of +176.2%

Key Metrics & Analysis

Financial Health

Revenue Growth176.20%
Profit Margin-104.96%
ROE-331.39%
ROA-45.11%
Debt/Equity81.02
P/B Ratio5.3
Op. Cash Flow$-9151533
Free Cash Flow$-5859845

Technical Analysis

TrendBearish
RSI34.5
Support$0.79
Resistance$1.10
MA 20$0.98
MA 50$1.01
MA 200$1.05
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48

Valuation

GradeFair
TypeGrowth

Risk Assessment

Beta1.34
Volatility52.33%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.